Atrioventricular node disorder
diseaseOn this page
Also known as atrioventricular node diseaseatrioventricular node disease or disorderdisease of atrioventricular nodedisease or disorder of atrioventricular nodedisorder of atrioventricular node
Summary
Atrioventricular node disorder (MONDO:0005476) is a disease. A subtype of conduction system disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | atrioventricular node disorder |
| Mondo ID | MONDO:0005476 |
| EFO | EFO:0005305 |
| UMLS | C3276314 |
| MedGen | 477944 |
| Anatomy (UBERON) | UBERON:0002352 |
| Is cancer (heuristic) | no |
Also known as: atrioventricular node disease · atrioventricular node disease or disorder · disease of atrioventricular node · disease or disorder of atrioventricular node · disorder of atrioventricular node
Disease family
This is a subtype of conduction system disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › muscle tissue disorder › conduction system disorder › atrioventricular node disorder
Related subtypes (3): sinoatrial node disorder, progressive familial heart block, type 1A, atrial conduction disease
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.